Press Room

Prostate cancer survivors, physicians and cancer advocates gathered at the Pennsylvania State Capitol to urge swift passage of legislation that would expand access to prostate cancer screening for high-risk men. The proposals--House Bill 281 and Senate Bill 447—would remove cost-sharing requirements for those at high-risk of developing prostate cancer that currently keep too many Pennsylvanians from getting screened.

Austin, TX. – With the end of the 2025 Texas legislative session, the American Cancer Society Cancer Action Network (ACS CAN) is optimistic that more people will have access to cancer prevention and early detection services and reinforces its commitment to this effort.   

Pennsylvania lawmakers have taken a critical step in efforts to prevent cancer and reduce its burden on Pennsylvanians by introducing HB 281 and SB 447. If passed, the legislation would eliminate out-of-pocket costs for lifesaving prostate cancer screenings for men at high-risk of developing prostate cancer, thus reducing barriers and increasing access to care for men over 40 with certain high-risk factors.

Según varios informes de prensa, el expresidente Joe Biden ha sido diagnosticado con una forma agresiva de cáncer de próstata que se ha extendido a los huesos.

Over 120 volunteer advocates from across Pennsylvania, including cancer survivors, patients and caregivers, convened at the state Capitol yesterday for ‘Cancer Action Day,’ an event hosted annually by the American Cancer Society Cancer Action Network (ACS CAN). Advocates met with their state lawmakers and urged them to support policies that aid in the fight against cancer. 

Volunteer advocates, including cancer survivors, patients,

Activistas de la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer lamentan la pérdida del Rep. Raúl Grijalva, quien falleció el jueves debido a complicaciones causadas por un cáncer de pulmón. 

Today, the U.S. House passed The Full-Year Continuing Appropriations and Extensions Act, 2025. It contains no increases for federal cancer research or prevention funding and significant cuts to Congressionally Directed Medical Research Programs (CDMRP), in which cancer is the largest recipient of funds. 

Los representantes Neal Dunn, M.D. (R-FL) e Yvette Clarke (D-NY) presentaron ante la Cámara Baja el proyecto de ley llamado Ley sobre las Pruebas de Antígeno Prostático Específico para Hombres en Alto Riesgo con Seguro (PSA Screening for HIM Act).

Bipartisan legislation that would remove financial barriers to prostate cancer screening was introduced today in the U.S. Senate. Sponsored by Senators John Boozman (R-AR) and Cory Booker (D-NJ), the Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act would waive cost-sharing requirements such as deductibles, copayments and coinsurance, for prostate cancer screening tests for men with the highest risk of prostate cancer, including Black men and those with a family history of the disease.